Antidotes to anthrax lethal factor intoxication. Part 2: Structural modifications leading to improved in vivo efficacy
摘要:
New anthrax lethal factor inhibitors (LFIs) were designed based upon previously identified potent inhibitors 1a and 2. Combining the new core structures with modifications to the C2-side chain yielded analogs with improved efficacy in the rat lethal toxin model. (C) 2011 Elsevier Ltd. All rights reserved.
Hydroxamic acid derivatives of 3-Phenyl propionic acids useful as therapeutic agents for treating anthrax poisoning
申请人:Johnson Alan T.
公开号:US20080188566A1
公开(公告)日:2008-08-07
Compounds having the formula
wherein the symbols have the meaning described in the specification are hydroxamic acid derivatives of 3-phenyl-propionic acid and capable of inhibiting the lethal effects of infection by anthrax bacteria and are useful in the treatment of poisoning by anthrax.
Hydroxamic acid derivatives of aniline useful as therapeutic agents for treating anthrax poisoning
申请人:Johnson Alan T.
公开号:US20120157462A1
公开(公告)日:2012-06-21
Compounds having the formula
wherein the symbols have the meaning described in the specification are hydroxamic acid derivatives of aniline and capable of inhibiting the lethal effects of infection by anthrax bacteria and are useful in the treatment of poisoning by anthrax.
Hydroxamic acid derivatives of 3-phenyl propionic acids useful as therapeutic agents for treating anthrax poisoning
申请人:PanThera Biopharma, LLC
公开号:US07807720B2
公开(公告)日:2010-10-05
Compounds having the formula
wherein the symbols have the meaning described in the specification are hydroxamic acid derivatives of 3-phenyl-propionic acid and capable of inhibiting the lethal effects of infection by anthrax bacteria and are useful in the treatment of poisoning by anthrax.